Clinical trial
Single Arm,Two Phase,Multicenter Trial to Evaluating the Efficacy and Safety of the CAR-T for Liver Cancer
NCT02729493 is registered in ClinicalTrials.gov with Sinobioway Cell Therapy Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Single Arm,Two Phase,Multicenter Trial to Evaluating the Efficacy and Safety of the CAR-T for Liver Cancer
- Lead sponsor
- Sinobioway Cell Therapy Co., Ltd.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 14, 2015
- Completion date
- November 30, 2019
- Enrollment
- 25 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.